Stock Comparison
MDLN vs RMD
Medline Inc. Class A Common Stock and ResMed Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$49.88B
$31.68B
P/E (TTM)
46.4
20.9
Forward P/E
24.4
18.7
Price/Sales
1.7
5.6
Price/Book
2.8
4.8
EV/EBITDA
15.7
14.4
Dividend Yield
—
1.06%
Profitability
Net Margin
3.31%
27.44%
Operating Margin
7.04%
34.28%
Return on Equity
4.94%
24.30%
Return on Assets
3.01%
14.00%
Growth (YoY)
Revenue Growth
11.60%
8.60%
Earnings Growth
262.00%
2.30%
Price & Risk
Beta
—
0.7
52-Week High
$49.99
$291.46
52-Week Low
$33.19
$182.82
Analyst Target
$46.58
$248.33
Compare MDLN and RMD your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.